Limoneira Co (LMNR) reported $132.4M in revenue over the twelve months to Apr 30, 2026, down 25.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Volatile margins turned FY2025 revenue pressure into losses, cash consumption, and renewed debt reliance despite improved current liquidity.
FY2025's net loss reached-$16.0M , while operating cash flow was-$6.0M ; the narrower cash loss reflects substantial noncash charges, but earnings still failed to convert into cash. Gross margin compressed from13.9% in FY2024 to3.1% in FY2025, indicating a margin shock—not merely weaker sales volume—drove the deterioration.
Liabilities increased from
Gross profit fell from
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Limoneira Co's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Not available for Limoneira Co, and counted as zero in the overall score.
Limoneira Co scores 1.56, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($245.9M) relative to total liabilities ($120.3M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Limoneira Co passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
Limoneira Co reported a net loss of $16.0M while operations used $6.0M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Limoneira Co generated $159.7M in revenue in fiscal year 2025. This represents a decrease of 16.6% from the prior year.
Limoneira Co's EBITDA was -$11.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 609.8% from the prior year.
Limoneira Co reported -$16.0M in net income in fiscal year 2025. This represents a decrease of 307.1% from the prior year.
Limoneira Co earned -$0.93 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 332.5% from the prior year.
Cash & Balance Sheet
Limoneira Co held $1.5M in cash against $72.5M in long-term debt as of fiscal year 2025.
Limoneira Co paid $0.30 per share in dividends in fiscal year 2025. That is unchanged from the prior year.
Not reported for fiscal year 2025.
Margins & Returns
Limoneira Co's gross margin was 3.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 10.9 percentage points from the prior year.
Limoneira Co's operating margin was -12.8% in fiscal year 2025, reflecting core business profitability. This is down 9.6 percentage points from the prior year.
Limoneira Co's net profit margin was -10.0% in fiscal year 2025, showing the share of revenue converted to profit. This is down 14.0 percentage points from the prior year.
Limoneira Co's ROE was -8.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 12.9 percentage points from the prior year.
Capital Allocation
None of these metrics is reported for fiscal year 2025.
LMNR Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $23.9M+31.4% | $18.2M-57.5% | $42.8M-9.8% | $47.5M+35.2% | $35.1M+2.4% | $34.3M-21.8% | $43.9M-30.7% | $63.3M |
| Cost of Revenue | $23.2M+0.6% | $23.0M-51.6% | $47.6M+13.1% | $42.0M+32.6% | $31.7M-5.4% | $33.5M-15.9% | $39.8M-12.4% | $45.4M |
| Gross Profit | $768K+116.0% | -$4.8M-1.6% | -$4.7M-187.3% | $5.4M+58.9% | $3.4M+323.7% | $806K-80.1% | $4.0M-77.4% | $17.9M |
| SG&A Expenses | $5.4M+18.0% | $4.6M-37.2% | $7.3M+47.5% | $5.0M-13.5% | $5.7M-11.5% | $6.5M+12.5% | $5.8M-17.7% | $7.0M |
| Operating Income | -$21.7M-105.6% | -$10.6M+4.8% | -$11.1M-1659.4% | -$630K+81.2% | -$3.3M+37.4% | -$5.3M-94.3% | -$2.8M-130.6% | $9.0M |
| Income Tax | -$5.3M-95.9% | -$2.7M+1.1% | -$2.7M-1597.3% | $182K-39.5% | $301K+112.5% | -$2.4M-847.5% | $322K-89.3% | $3.0M |
| Net Income | -$21.4M-127.2% | -$9.4M-8.5% | -$8.7M-916.5% | -$855K+74.6% | -$3.4M-9.3% | -$3.1M-65.4% | -$1.9M-128.2% | $6.6M |
| EPS (Diluted) | -$1.20-126.4% | -$0.53-6.0% | -$0.50-733.3% | -$0.06+70.0% | -$0.20-11.1% | -$0.18-63.6% | -$0.11-131.4% | $0.35 |
Not reported in any period shown, so not listed: R&D Expenses, Interest Expense.
LMNR Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $293.8M-4.4% | $307.5M-1.2% | $311.1M+3.7% | $299.9M+1.1% | $296.6M-1.6% | $301.4M+0.9% | $298.8M-2.8% | $307.3M |
| Current Assets | $41.4M+59.2% | $26.0M-35.8% | $40.5M-12.6% | $46.3M+55.2% | $29.8M+4.8% | $28.5M+10.1% | $25.8M-27.2% | $35.5M |
| Cash & Equivalents | $891K-29.7% | $1.3M-16.0% | $1.5M-28.5% | $2.1M+1.3% | $2.1M+83.8% | $1.1M-62.2% | $3.0M+174.9% | $1.1M |
| Accounts Receivable | $12.3M+19.7% | $10.3M-33.4% | $15.4M-20.9% | $19.5M+23.9% | $15.8M-1.1% | $15.9M+8.1% | $14.7M-31.1% | $21.4M |
| Goodwill | $1.4M0.0% | $1.4M-8.8% | $1.5M+0.3% | $1.5M-0.3% | $1.5M+0.3% | $1.5M-0.2% | $1.5M-0.1% | $1.5M |
| Total Liabilities | $130.1M+2.5% | $126.9M+5.5% | $120.3M+10.6% | $108.8M+5.5% | $103.2M-0.8% | $104.0M+8.0% | $96.3M-5.2% | $101.6M |
| Current Liabilities | $24.7M+10.3% | $22.4M-25.6% | $30.1M+16.7% | $25.8M-9.6% | $28.5M+4.8% | $27.2M-21.8% | $34.8M-8.9% | $38.2M |
| Long-Term Debt | $93.7M+4.2% | $89.9M+24.1% | $72.5M+14.4% | $63.3M+15.3% | $54.9M-5.1% | $57.9M+44.6% | $40.0M0.0% | $40.0M |
| Total Equity | $152.9M-10.0% | $169.8M-5.7% | $180.0M-0.1% | $180.3M-1.3% | $182.7M-2.1% | $186.5M-2.7% | $191.7M-1.6% | $194.9M |
| Retained Earnings | -$33.4M-178.8% | -$12.0M-1019.6% | -$1.1M-111.8% | $9.1M-20.4% | $11.4M-29.7% | $16.3M-21.9% | $20.8M-13.8% | $24.2M |
Not reported in any period shown, so not listed: Inventory.
LMNR Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$4.5M+61.9% | -$11.7M-1346.2% | $942K+131.7% | -$3.0M-133.2% | $8.9M+169.1% | -$12.9M-296.0% | $6.6M-73.2% | $24.6M |
| Investing Cash Flow | -$10K+99.7% | -$3.4M+59.9% | -$8.5M-153.4% | -$3.4M-11.2% | -$3.0M+13.7% | -$3.5M-39.5% | -$2.5M+33.5% | -$3.8M |
| Financing Cash Flow | $3.9M-74.7% | $15.3M+119.7% | $6.9M+9.6% | $6.3M+227.1% | -$5.0M-134.3% | $14.5M+766.3% | -$2.2M+89.7% | -$21.1M |
| Dividends Paid | $0-100.0% | $1.4M+0.3% | $1.4M0.0% | $1.4M+0.1% | $1.4M0.0% | $1.4M-0.1% | $1.4M0.0% | $1.4M |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Share Buybacks.
LMNR Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 3.2%+29.7pp | -26.4%-15.4pp | -11.1%-22.5pp | 11.4%+1.7pp | 9.7%+7.4pp | 2.4%-6.9pp | 9.2%-19.0pp | 28.2% |
| Operating Margin | -90.7%-32.7pp | -58.0%-32.1pp | -25.9%-24.5pp | -1.3%+8.2pp | -9.5%+6.1pp | -15.6%-9.3pp | -6.3%-20.5pp | 14.2% |
| Net Margin | -89.5%-37.7pp | -51.8%-31.5pp | -20.3%-18.5pp | -1.8%+7.8pp | -9.6%-0.6pp | -9.0%-4.7pp | -4.2%-14.6pp | 10.4% |
| Return on Equity | -14.0%-8.5pp | -5.5%-0.7pp | -4.8%-4.4pp | -0.5%+1.4pp | -1.8%-0.2pp | -1.7%-0.7pp | -1.0%-4.3pp | 3.4% |
| Return on Assets | -7.3%-4.2pp | -3.1%-0.3pp | -2.8%-2.5pp | -0.3%+0.8pp | -1.1%-0.1pp | -1.0%-0.4pp | -0.6%-2.8pp | 2.1% |
| Current Ratio | 1.68+0.5x | 1.16-0.2x | 1.35-0.5x | 1.80+0.7x | 1.050.0x | 1.05+0.3x | 0.74-0.2x | 0.93 |
| Debt-to-Equity | 0.61+0.1x | 0.53+0.1x | 0.40+0.1x | 0.35+0.1x | 0.300.0x | 0.31+0.1x | 0.210.0x | 0.21 |
Not reported in any period shown, so not listed: FCF Margin.
Similar Companies
Where Limoneira Co Ranks
Frequently Asked Questions
What is Limoneira Co's annual revenue?
Limoneira Co (LMNR) reported $159.7M in total revenue for fiscal year 2025. This represents a -16.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Limoneira Co's revenue growing?
Limoneira Co (LMNR) revenue declined by 16.6% year-over-year, from $191.5M to $159.7M in fiscal year 2025.
Is Limoneira Co profitable?
No, Limoneira Co (LMNR) reported a net income of -$16.0M in fiscal year 2025, with a net profit margin of -10.0%.
What is Limoneira Co's EBITDA?
Limoneira Co (LMNR) had EBITDA of -$11.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Limoneira Co have?
As of fiscal year 2025, Limoneira Co (LMNR) had $1.5M in cash and equivalents against $72.5M in long-term debt.
What is Limoneira Co's gross margin?
Limoneira Co (LMNR) had a gross margin of 3.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Limoneira Co's operating margin?
Limoneira Co (LMNR) had an operating margin of -12.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Limoneira Co's net profit margin?
Limoneira Co (LMNR) had a net profit margin of -10.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Limoneira Co pay dividends?
Yes, Limoneira Co (LMNR) paid $0.30 per share in dividends during fiscal year 2025.
What is Limoneira Co's return on equity (ROE)?
Limoneira Co (LMNR) has a return on equity of -8.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Limoneira Co's operating cash flow?
Limoneira Co (LMNR) recorded an outflow of $6.0M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Limoneira Co's total assets?
Limoneira Co (LMNR) had $311.1M in total assets as of fiscal year 2025, including both current and long-term assets.
What is Limoneira Co's current ratio?
Limoneira Co (LMNR) had a current ratio of 1.35 as of fiscal year 2025, which is considered adequate.
What is Limoneira Co's debt-to-equity ratio?
Limoneira Co (LMNR) had a debt-to-equity ratio of 0.40 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Limoneira Co's return on assets (ROA)?
Limoneira Co (LMNR) had a return on assets of -5.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
How does Limoneira Co's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Limoneira Co (LMNR) held $1.5M in cash, cash equivalents and investments, and reported an operating cash outflow of $6.0M over that year. Dividing the one by the other, the reported balance equals about 3 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Limoneira Co's Altman Z-Score?
Limoneira Co (LMNR) has an Altman Z-Score of 1.56, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Limoneira Co's Piotroski F-Score?
Limoneira Co (LMNR) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Limoneira Co's earnings high quality?
Limoneira Co (LMNR) reported a net loss of $16.0M while operations used $6.0M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Limoneira Co?
Limoneira Co (LMNR) scores 33 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.